| Year |
Citation |
Score |
| 2012 |
Moskowitz SM, Brannon MK, Dasgupta N, Pier M, Sgambati N, Miller AK, Selgrade SE, Miller SI, Denton M, Conway SP, Johansen HK, Høiby N. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrobial Agents and Chemotherapy. 56: 1019-30. PMID 22106224 DOI: 10.1128/Aac.05829-11 |
0.569 |
|
| 2011 |
Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, Høiby N, Moskowitz SM. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrobial Agents and Chemotherapy. 55: 5761-9. PMID 21968359 DOI: 10.1128/Aac.05391-11 |
0.572 |
|
| 2007 |
D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Déziel E, Smith EE, Nguyen H, Ernst RK, Larson Freeman TJ, Spencer DH, Brittnacher M, Hayden HS, Selgrade S, Klausen M, Goodlett DR, et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Molecular Microbiology. 64: 512-33. PMID 17493132 DOI: 10.1111/J.1365-2958.2007.05678.X |
0.506 |
|
| 2003 |
Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environmental Microbiology. 5: 1341-9. PMID 14641578 DOI: 10.1111/J.1462-2920.2003.00518.X |
0.486 |
|
| Show low-probability matches. |